Skip to main content
Log in

The biology of Kaposi’s sarcoma-associated herpesvirus and the infection of human immunodeficiency virus

  • Published:
Virologica Sinica

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is discovered in 1994 from Kaposi’s sarcoma (KS) lesion of an acquired immunodeficiency syndrome (AIDS) patient. In addition to its association with KS, KSHV has also been implicated as the causative agent of two other AIDS-associated malignancies: primary effusion lymphoma (PEL) and multicentric Castleman’s disease (MCD). KSHV is a complex DNA virus that not only has the ability to promote cellular growth and survival for tumor development, but also can provoke deregulated angiogenesis, inflammation, and modulate the patient’s immune system in favor of tumor growth. As KSHV is a necessary but not sufficient etiological factor for KS, human immunodeficiency virus (HIV) is a very important cofactor. Here we review the basic information about the biology of KSHV, development of pathogenesis and interaction between KSHV and HIV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ablashi D, Chatlynne L, Cooper H,et al. 1999. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer, 81: 893–897.

    Article  PubMed  CAS  Google Scholar 

  2. Ablashi D V, Chatlynne L G, Whitman J E Jr,et al. 2002. Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev, 15: 439–464.

    Article  PubMed  Google Scholar 

  3. Albini A, Paglieri I, Orengo G,et al. 1997. The beta-core fragment of human chorionic gonadotrophin inhibits growth of Kaposi’s sarcoma-derived cells and a new immortalized Kaposi’s sarcoma cell line. AIDS, 11: 713–721.

    Article  PubMed  CAS  Google Scholar 

  4. Aoki Y, Tosato G. 2003. Targeted inhibition of angiogenic factors in AIDS-related disorders. Curr Drug Targets Infect Disord, 3: 115–128.

    Article  PubMed  CAS  Google Scholar 

  5. Aoki Y, Tosato G. 2004. HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood, 104: 810–814.

    Article  PubMed  CAS  Google Scholar 

  6. Atkinson J, Edlin B R, Engels E A,et al. 2003. Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis, 187: 974–981.

    Article  PubMed  Google Scholar 

  7. Bechtel J T, Liang Y, Hvidding J,et al. 2003. Host range of Kaposi’s sarcoma-associated herpesvirus in cultured cells. J Virol, 77: 6474–6481.

    Article  PubMed  CAS  Google Scholar 

  8. Beral V. 1991. Epidemiology of Kaposi’s sarcoma. Cancer Surv, 10: 5–22.

    PubMed  CAS  Google Scholar 

  9. Beral V, Peterman T A, Berkelman R L,et al. 1990. Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet, 335: 123–128.

    Article  PubMed  CAS  Google Scholar 

  10. Blackbourn D J, Lennette E T, Ambroziak J,et al. 1998. Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis, 177: 213–216.

    Article  PubMed  CAS  Google Scholar 

  11. Blackbourn D J, Osmond D, Levy J A,et al. 1999. Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners. J Infect Dis, 179: 237–239.

    Article  PubMed  CAS  Google Scholar 

  12. Borkovic S P, Schwartz R A. 1981. Kaposi’s sarcoma presenting in the homosexual man — a new and striking phenomenon! Ariz Med, 38: 902–904.

    PubMed  CAS  Google Scholar 

  13. Burysek L, Yeow W S, Lubyova B,et al. 1999. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol, 73: 7334–7342.

    PubMed  CAS  Google Scholar 

  14. Cannon M J, Dollard S C, Black J B,et al. 2003. Risk factors for Kaposi’s sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS, 17: 215–222.

    Article  PubMed  CAS  Google Scholar 

  15. Carbone A, Gaidano G. 1997. HHV-8-positive body-cavity-based lymphoma: a novel lymphoma entity. Br J Haematol, 97: 515–522.

    Article  PubMed  CAS  Google Scholar 

  16. Caselli E, Menegazzi P, Bracci A,et al. 2001. Human herpesvirus-8 (Kaposi’s sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR. J Gen Virol, 82: 1965–1970.

    PubMed  CAS  Google Scholar 

  17. Caselli E, Galvan M, Santoni F,et al. 2003. Human herpesvirus-8 (Kaposi’s sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection. J Gen Virol, 84: 1123–1131.

    Article  PubMed  CAS  Google Scholar 

  18. Caselli E, Galvan M, Cassai E,et al. 2003. Transient expression of human herpesvirus-8 (Kaposi’s sarcoma-associated herpesvirus) ORF50 enhances HIV-1 replication. Intervirology, 46: 141–149.

    Article  PubMed  CAS  Google Scholar 

  19. Caselli E, Galvan M, Cassai E,et al. 2005. Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells. Blood, 106: 2790–2797.

    Article  PubMed  CAS  Google Scholar 

  20. Cathomas G, McGandy C E, Terracciano L M,et al. 1996. Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma. J Clin Pathol, 49: 631–633.

    Article  PubMed  CAS  Google Scholar 

  21. Cesarman E, Chang Y, Moore P S,et al. 1995. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med, 332: 1186–1191.

    Article  PubMed  CAS  Google Scholar 

  22. Cesarman E. 2002. The role of Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent Results Cancer Res, 159: 27–37.

    PubMed  CAS  Google Scholar 

  23. Chang Y, Cesarman E, Pessin M S,et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science, 266: 1865–1869.

    Article  PubMed  CAS  Google Scholar 

  24. Chatlynne L G, Ablashi D V. 1999. Seroepidemiology of Kaposi’s sarcoma-associated herpesvirus (KSHV). Semin Cancer Biol, 9: 175–185.

    Article  PubMed  CAS  Google Scholar 

  25. Chatlynne L G, Lapps W, Handy M,et al. 1998. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immuno-deficiency syndrome patients, and Kaposi’s sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood, 92: 53–58.

    PubMed  CAS  Google Scholar 

  26. Cheng E H, Nicholas J, Bellows D S,et al. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A, 94: 690–694.

    Article  PubMed  CAS  Google Scholar 

  27. Child E S, Mann D J. 2001. Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence. Oncogene, 20: 3311–3322.

    Article  PubMed  CAS  Google Scholar 

  28. Couty J P, Geras-Raaka E, Weksler B B,et al. 2001. Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor signals through multiple pathways in endothelial cells. J Biol Chem, 276: 33805–33811.

    Article  PubMed  CAS  Google Scholar 

  29. de-The G, Bestetti G, van Beveren M,et al. 1999. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi’s sarcoma in East Africa. J Natl Cancer Inst, 91: 1888–1889.

    Article  PubMed  CAS  Google Scholar 

  30. Dedicoat M, Newton R, Alkharsah K R,et al. 2004. Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis, 190: 1068–1075.

    Article  PubMed  Google Scholar 

  31. Duus K M, Lentchitsky V, Wagenaar T,et al. 2004. Wild-type Kaposi’s sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J Virol, 78: 4074–4084.

    Article  PubMed  CAS  Google Scholar 

  32. Enbom M, Sheldon J, Lennette E,et al. 2000. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study. J Med Virol, 62: 498–504.

    Article  PubMed  CAS  Google Scholar 

  33. Engels E A, Sinclair M D, Biggar R J,et al. 2000. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta. Int J Cancer, 88: 1003–1008.

    Article  PubMed  CAS  Google Scholar 

  34. Ensoli B, Sgadari C, Barillari G,et al. 2001. Biology of Kaposi’s sarcoma. Eur J Cancer, 37: 1251–1269.

    Article  PubMed  CAS  Google Scholar 

  35. Ensoli B, Sturzl M, Monini P. 2001. Reactivation and role of HHV-8 in Kaposi’s sarcoma initiation. Adv Cancer Res, 81: 161–200.

    Article  PubMed  CAS  Google Scholar 

  36. Field N, Low W, Daniels M,et al. 2003. KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci, 116: 3721–3728.

    Article  PubMed  CAS  Google Scholar 

  37. Friborg J Jr, Kong W, Hottiger M O,et al. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature, 402: 889–894.

    PubMed  CAS  Google Scholar 

  38. Friedman-Kien A E. 1981. Disseminated Kaposi’s sarcoma syndrome in young homosexual men. J Am Acad Dermatol, 5: 468–471.

    Article  PubMed  CAS  Google Scholar 

  39. Gambus G, Bourboulia D, Esteve A,et al. 2001. Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS, 15: 1167–1174.

    Article  PubMed  CAS  Google Scholar 

  40. Gao S J, Boshoff C, Jayachandra S,et al. 1997. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene, 15: 1979–1985.

    Article  PubMed  CAS  Google Scholar 

  41. Gao S J, Kingsley L, Li M,et al. 1996. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nat Med, 2: 925–928.

    Article  PubMed  CAS  Google Scholar 

  42. Gessain A, Mauclere P, van Beveren M,et al. 1999. Human herpesvirus 8 primary infection occurs during childhood in Cameroon, Central Africa. Int J Cancer, 81: 189–192.

    Article  PubMed  CAS  Google Scholar 

  43. Giraldo G, Beth E, Haguenau F. 1972. Herpes-type virus particles in tissue culture of Kaposi’s sarcoma from different geographic regions. J Natl Cancer Inst, 49: 1509–1526.

    PubMed  CAS  Google Scholar 

  44. Goedert J J, Cote T R, Virgo P,et al. 1998. Spectrum of AIDS-associated malignant disorders. Lancet, 351: 1833–1839.

    Article  PubMed  CAS  Google Scholar 

  45. Gottlieb G J, Ragaz A, Vogel J V,et al. 1981. A preliminary communication on extensively disseminated Kaposi’s sarcoma in young homosexual men. Am J Dermatopathol, 3: 111–114.

    Article  PubMed  CAS  Google Scholar 

  46. Grossman Z, Iscovich J, Schwartz F,et al. 2002. Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus8. Mayo Clin Proc, 77: 905–909.

    Article  PubMed  Google Scholar 

  47. Guasparri I, Keller S A, Cesarman E. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med, 199: 993–1003.

    Article  PubMed  CAS  Google Scholar 

  48. Guo H G, Pati S, Sadowska M,et al. 2004. Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J Virol, 78: 9336–9342.

    Article  PubMed  CAS  Google Scholar 

  49. Gwack Y, Hwang S, Byun H,et al. 2001. Kaposi’s sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J Virol, 75: 6245–6248.

    Article  PubMed  CAS  Google Scholar 

  50. Hengge U R, Ruzicka T, Tyring S K,et al. 2002. Update on Kaposi’s sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman’s disease, and pleural effusion lymphoma. Lancet Infect Dis, 2: 344–352.

    Article  PubMed  Google Scholar 

  51. Hideshima T, Chauhan D, Teoh G,et al. 2000. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi’s sarcoma-associated herpes virus-encoded viral interleukin 6. Clin Cancer Res, 6: 1180–1189.

    PubMed  CAS  Google Scholar 

  52. Huang L M, Chao M F, Chen M Y,et al. 2001. Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1. J Biol Chem, 276: 13427–13432.

    Article  PubMed  CAS  Google Scholar 

  53. Hymes K B, Cheung T, Greene J B,et al. 1981. Kaposi’s sarcoma in homosexual men-a report of eight cases. Lancet, 2: 598–600.

    Article  PubMed  CAS  Google Scholar 

  54. Hyun T S, Subramanian C, Cotter M A 2nd,et al. 2001. Latency-associated nuclear antigen encoded by Kaposi’s sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells. J Virol, 75: 8761–8771.

    Article  PubMed  CAS  Google Scholar 

  55. Iscovich J, Boffetta P, Franceschi S,et al. 2000. Classic kaposi sarcoma: epidemiology and risk factors. Cancer, 88: 500–517.

    Article  PubMed  CAS  Google Scholar 

  56. Jacobson L P, Jenkins F J, Springer G,et al. 2000. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi’s sarcoma. J Infect Dis, 181: 1940–1949.

    Article  PubMed  CAS  Google Scholar 

  57. Juhasz A, Remenyik E, Konya J,et al. 2001. Prevalence and age distribution of human herpesvirus-8 specific antibodies in Hungarian blood donors. J Med Virol, 64: 526–530.

    Article  PubMed  CAS  Google Scholar 

  58. Juhasz I, Albelda S M, Elder D E,et al. 1993. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol, 143: 528–537.

    PubMed  CAS  Google Scholar 

  59. Kaaya S F, Leshabari M T, Mbwambo J K. 1998. Risk behaviors and vulnerability to HIV infection among Tanzanian youth. J Health Popul Dev Ctries, 1: 51–60.

    PubMed  CAS  Google Scholar 

  60. Kaposi M. 1872. Idiopathisches multiples Pigmentsarkom der Haut. Arch Dermatol Syph, 4: 265–273.

    Article  Google Scholar 

  61. Kirchhoff S, Sebens T, Baumann S,et al. 2002. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter. J Immunol, 168: 1226–1234.

    PubMed  CAS  Google Scholar 

  62. Lang M E, Lottersberger C, Roth B,et al. 1997. Induction of apoptosis in Kaposi’s sarcoma spindle cell cultures by the subunits of human chorionic gonadotropin. AIDS, 11: 1333–1340.

    PubMed  CAS  Google Scholar 

  63. Lennette E T, Blackbourn D J, Levy J A. 1996. Antibodies to human herpesvirus type 8 in the general population and in Kaposi’s sarcoma patients. Lancet, 348: 858–861.

    Article  PubMed  CAS  Google Scholar 

  64. Li M, Lee H, Yoon D W,et al. 1997. Kaposi’s sarcoma-associated herpesvirus encodes a functional cyclin. J Virol, 71: 1984–1991.

    PubMed  CAS  Google Scholar 

  65. Liu L, Eby M T, Rathore N,et al. 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem, 277: 13745–13751.

    Article  PubMed  CAS  Google Scholar 

  66. Lubyova B, Pitha P M. 2000. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol, 74: 8194–8201.

    Article  PubMed  CAS  Google Scholar 

  67. Martin J N, Ganem D E, Osmond D H,et al. 1998. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med, 338: 948–954.

    Article  PubMed  CAS  Google Scholar 

  68. Martin R W 3rd, Hood A F, Farmer E R. 1993. Kaposi sarcoma. Medicine (Baltimore), 72: 245–261.

    Google Scholar 

  69. Matta H, Chaudhary P M. 2004. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci U S A, 101: 9399–9404.

    Article  PubMed  CAS  Google Scholar 

  70. Mayama S, Cuevas L E, Sheldon J,et al. 1998. Prevalence and transmission of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer, 77: 817–820.

    Article  PubMed  CAS  Google Scholar 

  71. Mbulaiteye S M, Biggar R J, Goedert J J,et al. 2003. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr, 32: 527–533.

    Article  PubMed  Google Scholar 

  72. Mbulaiteye S M, Pfeiffer R M, Whitby D,et al. 2003. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis, 187: 1780–1785.

    Article  PubMed  Google Scholar 

  73. Mendez J C, Procop G W, Espy M J,et al. 1999. Relationship of HHV8 replication and Kaposi’s sarcoma after solid organ transplantation. Transplantation, 67: 1200–1201.

    Article  PubMed  CAS  Google Scholar 

  74. Merat R, Amara A, Lebbe C,et al. 2002. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi’s sarcoma-associated herpesvirus (KSHV) reactivation. Int J Cancer, 97: 791–795.

    Article  PubMed  CAS  Google Scholar 

  75. Mercader M, Taddeo B, Panella J R,et al. 2000. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol, 156: 1961–1971.

    PubMed  CAS  Google Scholar 

  76. Mercader M, Nickoloff B J, Foreman K E. 2001. Induction of human immunodeficiency virus 1 replication by human herpesvirus 8. Arch Pathol Lab Med, 125: 785–789.

    PubMed  CAS  Google Scholar 

  77. Molden J, Chang Y, You Y,et al. 1997. A Kaposi’s sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem, 272: 19625–19631.

    Article  PubMed  CAS  Google Scholar 

  78. Montaner S, Sodhi A, Pece S,et al. 2001. The Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res, 61: 2641–2648.

    PubMed  CAS  Google Scholar 

  79. Moore P S, Chang Y. 2001. Molecular virology of Kaposi’s sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci, 356: 499–516.

    Article  PubMed  CAS  Google Scholar 

  80. Moore P S, Kingsley L A, Holmberg S D,et al. 1996. Kaposi’s sarcoma-associated herpesvirus infection prior to onset of Kaposi’s sarcoma. AIDS, 10: 175–180.

    Article  PubMed  CAS  Google Scholar 

  81. Moore P S, Gao S J, Dominguez G,et al. 1996. Primary characterization of a herpesvirus agent associated with Kaposi’s sarcomae. J Virol, 70: 549–558.

    PubMed  CAS  Google Scholar 

  82. Munshi N, Ganju R K, Avraham S,et al. 1999. Kaposi’s sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-jun amino-terminal kinase/stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2. J Biol Chem, 274: 31863–31867.

    Article  PubMed  CAS  Google Scholar 

  83. Nador R G, Cesarman E, Chadburn A,et al. 1996. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood, 88: 645–656.

    PubMed  CAS  Google Scholar 

  84. Nakamura H, Li M, Zarycki J,et al. 2001. Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol, 75: 7572–7582.

    Article  PubMed  CAS  Google Scholar 

  85. Neipel F, Albrecht J C, Fleckenstein B. 1997. Cell-homologous genes in the Kaposi’s sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol, 71: 4187–4192.

    PubMed  CAS  Google Scholar 

  86. O’Brien T R, Kedes D, Ganem D,et al. 1999. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi’s sarcoma. J Infect Dis, 180: 1010–1017.

    Article  PubMed  CAS  Google Scholar 

  87. Oettle A G. 1962. Geographical and racial differences in the frequency of Kaposi’s sarcoma as evidence of environmental or genetic causes. Acta Unio Int Contra Cancrum, 18: 330–363.

    PubMed  CAS  Google Scholar 

  88. Olsen S J, Chang Y, Moore P S,et al. 1998. Increasing Kaposi’s sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi’s sarcoma endemic region, Zambia in 1985. AIDS, 12: 1921–1925.

    Article  PubMed  CAS  Google Scholar 

  89. Osborne J, Moore P S, Chang Y. 1999. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum Immunol, 60: 921–927.

    Article  PubMed  CAS  Google Scholar 

  90. Pati S, Cavrois M, Guo H G,et al. 2001. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi’s sarcoma pathogenesis. J Virol, 75: 8660–8673.

    Article  PubMed  CAS  Google Scholar 

  91. Pauk J, Huang M L, Brodie S J,et al. 2000. Mucosal shedding of human herpesvirus 8 in men. N Engl J Med, 343: 1369–1377.

    Article  PubMed  CAS  Google Scholar 

  92. Plancoulaine S, Abel L, van Beveren M,et al. 2000. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet, 356: 1062–1065.

    Article  PubMed  CAS  Google Scholar 

  93. Plancoulaine S, Abel L, Tregouet D,et al. 2004. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res, 64: 8782–8787.

    Article  PubMed  CAS  Google Scholar 

  94. Preiser W, Szep N I, Lang D,et al. 2001. Kaposi’s sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems. Med Microbiol Immunol, 190: 121–127.

    PubMed  CAS  Google Scholar 

  95. Rabkin C S, Janz S, Lash A,et al. 1997. Monoclonal origin of multicentric Kaposi’s sarcoma lesions. N Engl J Med, 336: 988–993.

    Article  PubMed  CAS  Google Scholar 

  96. Radkov S A, Kellam P, Boshoff C. 2000. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med, 6: 1121–1127.

    Article  PubMed  CAS  Google Scholar 

  97. Regamey N, Cathomas G, Schwager M,et al. 1998. High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol, 36: 1784–1786.

    PubMed  CAS  Google Scholar 

  98. Renne R, Blackbourn D, Whitby D,et al. 1998. Limited transmission of Kaposi’s sarcoma-associated herpesvirus in cultured cells. J Virol, 72: 5182–5188.

    PubMed  CAS  Google Scholar 

  99. Renne R, Lagunoff M, Zhong W,et al. 1996. The size and conformation of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol, 70: 8151–8154.

    PubMed  CAS  Google Scholar 

  100. Rivas C, Thlick A E, Parravicini C,et al. 2001. Kaposi’s sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol, 75: 429–438.

    Article  PubMed  CAS  Google Scholar 

  101. Russo J J, Bohenzky R A, Chien M C,et al. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A, 93: 14862–14867.

    Article  PubMed  CAS  Google Scholar 

  102. Samaniego F, Young D, Grimes C,et al. 2002. Vascular endothelial growth factor and Kaposi’s sarcoma cells in human skin grafts. Cell Growth Differ, 13: 387–395.

    PubMed  CAS  Google Scholar 

  103. Sarek G, Jarviluoma A, Ojala P M. 2006. KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood, 107: 725–732.

    Article  PubMed  CAS  Google Scholar 

  104. Sarid R, Flore O, Bohenzky R A,et al. 1998. Transcription mapping of the Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol, 72: 1005–1012.

    PubMed  CAS  Google Scholar 

  105. Sarid R, Sato T, Bohenzky R A,et al. 1997. Kaposi’s sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med, 3: 293–298.

    Article  PubMed  CAS  Google Scholar 

  106. Schulz T F. 2000. KSHV (HHV8) infection. J Infect, 41: 125–129.

    Article  PubMed  CAS  Google Scholar 

  107. Schwarz M, Murphy P M. 2001. Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor cons-titutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol, 167: 505–513.

    PubMed  CAS  Google Scholar 

  108. Seo T, Lee D, Shim Y S,et al. 2002. Viral interferon regulatory factor 1 of Kaposi’s sarcoma-associated herpesvirus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death. J Virol, 76: 8797–8807.

    Article  PubMed  CAS  Google Scholar 

  109. Seo T, Park J, Lee D,et al. 2001. Viral interferon regulatory factor 1 of Kaposi’s sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol, 75: 6193–6198.

    Article  PubMed  CAS  Google Scholar 

  110. Shin Y C, Nakamura H, Liang X,et al. 2006. Inhibition of the ATM/p53 signal transduction pathway by Kaposi’s sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol, 80: 2257–2266.

    Article  PubMed  CAS  Google Scholar 

  111. Siegal F P, Lopez C, Hammer G S,et al. 1981. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med, 305: 1439–1444.

    PubMed  CAS  Google Scholar 

  112. Sitas F, Carrara H, Beral V,et al. 1999. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med, 340: 1863–1871.

    Article  PubMed  CAS  Google Scholar 

  113. Smit M J, Verzijl D, Casarosa P,et al. 2002. Kaposi’s sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways. J Virol, 76: 1744–1752.

    Article  PubMed  CAS  Google Scholar 

  114. Soulier J, Grollet L, Oksenhendler E,et al. 1995. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood, 86: 1276–1280.

    PubMed  CAS  Google Scholar 

  115. Sternbach G, Varon J. 1995. Moritz Kaposi: idiopathic pigmented sarcoma of the skin. J Emerg Med, 13: 671–674.

    Article  PubMed  CAS  Google Scholar 

  116. Sturzl M, Hohenadl C, Zietz C,et al. 1999. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi’s sarcoma spindle cells. J Natl Cancer Inst, 91: 1725–1733.

    Article  PubMed  CAS  Google Scholar 

  117. Sun Q, Matta H, Chaudhary P M. 2005. Kaposi’s sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat. Retrovirology, 2: 9.

    Article  PubMed  CAS  Google Scholar 

  118. Wan X, Wang H, Nicholas J. 1999. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J Virol, 73: 8268–8278.

    PubMed  CAS  Google Scholar 

  119. West J T, Wood C. 2003. The role of Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression. Oncogene, 22: 5150–5163.

    Article  PubMed  CAS  Google Scholar 

  120. Whitby D, Howard M R, Tenant-Flowers M,et al. 1995. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet, 346: 799–802.

    Article  PubMed  CAS  Google Scholar 

  121. Whitby D, Luppi M, Barozzi P,et al. 1998. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst, 90: 395–397.

    Article  PubMed  CAS  Google Scholar 

  122. Zeng Y, Zhang X, Huang Z,et al. 2007. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi’s sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol, 81: 2401–2417.

    Article  PubMed  CAS  Google Scholar 

  123. Zhu F X, Chong J M, Wu L,et al. 2005. Virion proteins of Kaposi’s sarcoma-associated herpesvirus. J Virol, 79: 800–811.

    Article  PubMed  CAS  Google Scholar 

  124. Ziegler J L, Newton R, Katongole-Mbidde E,et al. 1997. Risk factors for Kaposi’s sarcoma in HIV-positive subjects in Uganda. AIDS, 11: 1619–1626. VIROLOGICA SINICA, December 2008, 23 (6):486–495

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chun Lu.

Additional information

Foundation items: Fok Ying Tung Education Foundation (101038) and Program for New Century Excellent Talents in Chinese Universities (NCET-05-0506).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qin, D., Lu, C. The biology of Kaposi’s sarcoma-associated herpesvirus and the infection of human immunodeficiency virus. Virol. Sin. 23, 473–485 (2008). https://doi.org/10.1007/s12250-008-2996-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-008-2996-x

Key words

CLC number

Navigation